American Bio Medica Corp (ABMC) Financial Statements (2024 and earlier)

Company Profile

Business Address 122 SMITH ROAD
KINDERHOOK, NY 12106
State of Incorp. NY
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments3411598411336
Cash and cash equivalents3411598411336
Receivables82323407370452348
Inventory, net of allowances, customer advances and progress billings 3794435368101,0191,473
Inventory 3794435368101,0191,473
Other undisclosed current assets274459139432997
Total current assets:7691,3401,1801,2271,6131,954
Noncurrent Assets
Operating lease, right-of-use asset 13 4173
Property, plant and equipment 466517576644718792
Intangible assets, net (including goodwill)  (206)108116123109
Intangible assets, net (excluding goodwill)  (206)108116123109
Other noncurrent assets 212121212121
Other undisclosed noncurrent assets  211 (3) 15
Total noncurrent assets: 500543746851862937
TOTAL ASSETS:1,2691,8831,9262,0782,4752,891
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,1681,059950990840808
Interest and dividends payable2522151311
Taxes payable18516414211589
Employee-related liabilities97107104278259
Accounts payable760682577652359374
Accrued liabilities 4087080777575
Debt 2,2301,543684388739533
Deferred compensation liability 10979138191167113
Other liabilities 903844522012
Other undisclosed current liabilities5105205665911
Total current liabilities:3,6022,8242,0211,6871,8251,477
Noncurrent Liabilities
Long-term debt and lease obligation:  34173  
Liabilities, other than long-term debt 6   719
Other liabilities     719
Operating lease, liability 634173
Other undisclosed noncurrent liabilities  (3)1,0791,108789772
Total noncurrent liabilities: 631,1611,181796791
Total liabilities:3,6082,8273,1822,8682,6212,268
Equity
Equity, attributable to parent, including:(2,339)(944)(1,256)(790)(146)623
Common stock481476377327323298
Additional paid in capital22,40323,39321,71721,43721,40421,170
Accumulated deficit(25,223)(23,813)(23,350)(22,554)(21,873)(20,845)
Other undisclosed equity, attributable to parent  (1,000)    
Total equity:(2,339)(944)(1,256)(790)(146)623
TOTAL LIABILITIES AND EQUITY:1,2691,8831,9262,0782,4752,891

Income Statement (P&L) ($ in thousands)

3/31/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues9132,2184,1473,6553,8724,914
Revenue, net4,914
Cost of revenue(1,106)(1,670)(2,909)(2,471)(2,584)(2,917)
Cost of goods and services sold      (2,917)
Other undisclosed gross profit90     
Gross profit:(103)5481,2381,1841,2881,997
Operating expenses(1,139)(1,727)(1,859)(1,777)(2,050)(2,308)
Operating loss:(1,242)(1,179)(621)(593)(762)(311)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
(166)718(173)(93)(264)(234)
Interest and debt expense(194)335(175)(265)(284)(272)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes (335)175265284272
Income (loss) from continuing operations before equity method investments, income taxes:(1,602)(461)(794)(686)(1,026)(545)
Other undisclosed income from continuing operations before income taxes194     
Income (loss) from continuing operations before income taxes:(1,408)(461)(794)(686)(1,026)(545)
Income tax expense (benefit)(2)(2)(2)5(2) 
Income (loss) from continuing operations:(1,410)(463)(796)(681)(1,028)(545)
Loss before gain (loss) on sale of properties:(463)(796)(681)(1,028)(545)
Other undisclosed net income2,820     
Net income (loss):1,410(463)(796)(681)(1,028)(545)
Other undisclosed net loss attributable to parent(2,820)     
Net income (loss) available to common stockholders, diluted:(1,410)(463)(796)(681)(1,028)(545)

Comprehensive Income ($ in thousands)

3/31/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net income (loss):1,410(463)(796)(681)(1,028)(545)
Comprehensive income (loss), net of tax, attributable to parent:1,410(463)(796)(681)(1,028)(545)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: